Navigation Links
Have You Had a Hysterectomy or Removal of Uterine Fibroids? Morcellator Device Withdrawn From Market Due To Cancer Risk
Date:7/31/2014

Toledo, Ohio (PRWEB) July 31, 2014

In a front-page story, the Wall Street Journal (7/30) reports that the pharmaceutical giant, Johnson & Johnson, is withdrawing its laparoscopic power morcellator due to data showing that it can spread undetected cancer. This important story has also been reported by Bloomberg News (7/31), Reuters (7/30), USA Today (7/31), the AP (7/30), the Pittsburgh Business Times (7/30) and TIME (7/30).

The morcellator tool is used during uterine procedures to, “slice up common uterine masses called fibroids, and uteruses themselves, into fragments so they can be removed in minimally invasive surgery.” (Wall Street Journal, 7/30)

J&J previously suspended the sale of new morcellators in April after the U.S. Food and Drug Administration issued a safety communication advising doctors not to use the tool. Specifically, FDA concluded that, “based on an analysis of currently available data, it poses a risk of spreading unsuspected cancerous tissue, notably uterine sarcomas, beyond the uterus.”

The FDA determined that approximately 1 in 350 women who are undergoing hysterectomy or myomectomy for fibroids have an unsuspected type of uterine cancer called uterine sarcoma. It further noted, “If laparoscopic power morcellation is performed in these women, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis, significantly worsening the patient’s likelihood of long-term survival.”

According to an article published in the Journal of the American Medical Association in March, more than 20,000 minimally invasive or robotic hysterectomies are done annually.

The law firm of Zoll, Kranz & Borgess, LLC (“ZKB”) devotes its practice to the field of pharmaceutical and medical device litigation. ZKB is dedicated to compelling companies to produce safer products. Injured clients and partnering attorneys from across the U.S. apprecia
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Study examines presence of uterine cancers at the time of hysterectomy using morcellation
2. Women’s Excellence Physicians Perform Successful Robotic Laparoscopic Hysterectomy to Remove 16 Week-Sized Fibroid Uterus; Small Incisions and Quick Recovery Result
3. Study Says Using the da Vinci Surgical Robot for a Hysterectomy Fails to Cut Complications and May Raise Pneumonia Risk, Notes Parker Waichman LLP
4. Da Vinci Robot Lawsuit Lawyers at Wright & Schulte LLC Disturbed by New Study Examining Risks and Benefits of Robotic Surgery Hysterectomy
5. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on New Study Findings that Casts Doubt on Robot-Assisted Hysterectomy
6. Piece of da Vinci Surgical Robot Instrument Breaks off Inside Woman During Hysterectomy; It’s Found Following Months of Suffering, Parker Waichman LLP Notes
7. Johns Hopkins surgeons among the first in the country to perform a robotic single-site hysterectomy
8. Hysterectomy May Not Raise Heart Risks After All: Study
9. Estrogen helps keep joint pain at bay after hysterectomy
10. Robotic Surgery for Hysterectomy Often Not Best Option, Ob/Gyn Group Says
11. Delaying radiation therapy after hysterectomy ups risk of uterine cancer recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... ... Ticket Down is a reliable source for authentic tickets for the 2015 ... festival will end on Sunday, August 2nd. , Music fans have traveled ... unique and unbelievably popular festival attracts the best in entertainment from around the world. ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Sculpted Contours ... the CoolSmooth PRO this week. Zeltiq Aesthetics released this new applicator in the ... January 2014 for treating the outer thighs. The original applicator required a 2 ...
(Date:7/31/2015)... ... , ... M3 USA MDLinx.com, source of the Smartest Doc Board Exam Prep ... , The additions of Gastroenterology, Pulmonology and Allergy/Immunology round out an already robust selection ... exam easy and painless. MDLinx offers thousands of board-exam style questions and exam-specific ...
(Date:7/31/2015)... (PRWEB) , ... July 31, ... ... Jason T. Brown’s live lecture on pharmaceutical negligence is now available online ... was well received with a 94% approval rating from the nationwide audience. ...
(Date:7/31/2015)... IL (PRWEB) , ... July 31, 2015 , ... Creating ... IVF , is in pursuit of a visionary image that goes beyond the boundaries ... UAE, New Hope IVF has reached extraordinary heights with dependable patient support, affordable treatments, ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 3
... with ties to convicted lobbyist Jack Abramoff , , ... new investigative report today called "Viewers Beware of Anti-Health Care ... in eight states, including South Dakota, to oppose health care ... Foundation, which has a record as a right-wing political operation ...
... after treatment , MONDAY, June 1 (HealthDay News) -- ... screenings for second cancers as they reach adulthood. , ... after beating their disease, two new studies show. , ... cancer survivors are more likely to develop a new ...
... , Kids Learn the Link between Healthy Living and Reducing ... /PRNewswire/ -- Ten year olds aren,t ... this age could lead to stroke risk factors. A program ... primer on leading a healthy lifestyle. In conjunction with ...
... , Group led by conservative political operative with ties to ... Public Campaign Action Fund issued a new investigative report ... the group behind the political ads, currently running in eight ... the Americans for Prosperity Foundation, which has a record as ...
... community will increase collaboration and resource-sharing in global PD ... 1 The Michael J. Fox Foundation for Parkinson,s ... pdonlineresearch.org ), a resource-rich virtual workplace that MJFF hopes ... and funders collaborating and conversing across the globe. MJFF,s ...
... Australia, and MENLO PARK, California U.S.A. (June 1st, ... that the latest data from its pivotal study ... leukemia (CML) was the subject of an oral ... Society of Clinical Oncology (ASCO) Annual Meeting in ...
Cached Medicine News:Health News:"Viewers Beware" Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in South Dakota 2Health News:Many Childhood Cancer Survivors Not Checking for Second Malignancies 2Health News:Many Childhood Cancer Survivors Not Checking for Second Malignancies 3Health News:Sacred Heart Hospital Starts to Expose Students to Stroke Awareness at an Early Age 2Health News:'Viewers Beware' Report By Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running In Eight States 2Health News:Michael J. Fox Foundation Announces Launch of PD Online Research 2Health News:Michael J. Fox Foundation Announces Launch of PD Online Research 3Health News:ChemGenex's omacetaxine may provide first viable treatment option for highly resistant form of CML 2
(Date:7/31/2015)... LAKE, N.J. and SAN DIEGO ... today that its parent company Eisai Co., Ltd. (Headquarters: ... Haruo Naito , "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: ... CEO: Dr. Helen Torley , "NASDAQ: HALO") have ... mesylate (brand name: Halaven ® , "eribulin") in combination ...
(Date:7/31/2015)... , July 31, 2015 ... for video, data and cloud computing operators has ... leading pharma giant for Internet of Things (IoT) ... applications offered on subscription model.      ... giant is striving for business innovations to make ...
(Date:7/30/2015)... , July 30, 2015  ResMed ... has signed a definitive agreement to acquire ... non-invasive ventilation and sleep-disordered breathing medical devices ... innovation and market reputation in China, combined with ResMed,s global leadership in sleep ... in China suffering ...
Breaking Medicine Technology:Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... 11 Percent Fewer RA Patients,Reported Job Loss ... Methotrexate Alone, BARCELONA, Spain, June 15, 2007 ... the most common causes of,disability in the ... that,rheumatoid arthritis (RA) patients treated with Abbott's ...
... WYCOMBE, England, June 18, 2007 /PRNewswire/ -- Previously,undisclosed ... has the,potential to protect against all strains of ... PepTcell, at the 2007,Options for the Control of ... pre-clinical results, which will be published in the,European ...
Cached Medicine Technology:Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 3Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 4Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 5Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 6Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 7New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: